1. Home
  2. TIRX vs SPRO Comparison

TIRX vs SPRO Comparison

Compare TIRX & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIRX
  • SPRO
  • Stock Information
  • Founded
  • TIRX 2010
  • SPRO 2013
  • Country
  • TIRX China
  • SPRO United States
  • Employees
  • TIRX N/A
  • SPRO N/A
  • Industry
  • TIRX Specialty Insurers
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIRX Finance
  • SPRO Health Care
  • Exchange
  • TIRX Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • TIRX 118.4M
  • SPRO 121.0M
  • IPO Year
  • TIRX 2021
  • SPRO 2017
  • Fundamental
  • Price
  • TIRX $2.66
  • SPRO $1.90
  • Analyst Decision
  • TIRX
  • SPRO Buy
  • Analyst Count
  • TIRX 0
  • SPRO 4
  • Target Price
  • TIRX N/A
  • SPRO $5.00
  • AVG Volume (30 Days)
  • TIRX 54.5K
  • SPRO 339.6K
  • Earning Date
  • TIRX 08-22-2025
  • SPRO 11-13-2025
  • Dividend Yield
  • TIRX N/A
  • SPRO N/A
  • EPS Growth
  • TIRX N/A
  • SPRO N/A
  • EPS
  • TIRX N/A
  • SPRO N/A
  • Revenue
  • TIRX N/A
  • SPRO $48,576,000.00
  • Revenue This Year
  • TIRX N/A
  • SPRO N/A
  • Revenue Next Year
  • TIRX N/A
  • SPRO N/A
  • P/E Ratio
  • TIRX N/A
  • SPRO N/A
  • Revenue Growth
  • TIRX 158.74
  • SPRO N/A
  • 52 Week Low
  • TIRX $2.08
  • SPRO $0.51
  • 52 Week High
  • TIRX $13.25
  • SPRO $3.22
  • Technical
  • Relative Strength Index (RSI)
  • TIRX 35.77
  • SPRO 40.19
  • Support Level
  • TIRX $2.50
  • SPRO $1.91
  • Resistance Level
  • TIRX $3.30
  • SPRO $2.18
  • Average True Range (ATR)
  • TIRX 0.39
  • SPRO 0.10
  • MACD
  • TIRX 0.07
  • SPRO 0.00
  • Stochastic Oscillator
  • TIRX 42.34
  • SPRO 14.49

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: